Sonal Naik - DMCC SPECIALITY Company Officer
| DMCC Stock | 305.55 3.65 1.21% |
Executive
Sonal Naik is Company Officer of DMCC SPECIALITY CHEMICALS
| Address | Prospect Chambers, Mumbai, India, 400001 |
| Phone | 91 22 2204 8881 |
| Web | https://www.dmcc.com |
DMCC SPECIALITY Management Efficiency
The company has return on total asset (ROA) of 0.0665 % which means that it generated a profit of $0.0665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. DMCC SPECIALITY's management efficiency ratios could be used to measure how well DMCC SPECIALITY manages its routine affairs as well as how well it operates its assets and liabilities. At this time, DMCC SPECIALITY's Non Currrent Assets Other are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 162 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 1.4 B in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Suresh Bhise | JB Chemicals Pharmaceuticals | 59 | |
| Pardeep Khanna | IOL Chemicals and | 55 | |
| MCA MSc | Nucleus Software Exports | 60 | |
| Pradeep Malik | Nucleus Software Exports | N/A | |
| Bhushan Sachdeva | JB Chemicals Pharmaceuticals | N/A | |
| Ashwani Arora | Nucleus Software Exports | 52 | |
| Gyanendra BS | Tata Chemicals Limited | 59 | |
| Vikas Vij | IOL Chemicals and | 57 | |
| Bhagwat Deora | JB Chemicals Pharmaceuticals | 42 | |
| Sunetra Bhattacharya | R S Software | N/A | |
| Swaminathan Nagarajan | Tata Chemicals Limited | N/A | |
| H Chaddha | FCS Software Solutions | N/A | |
| Shrishti Andearson | R S Software | N/A | |
| Narendra Sah | FCS Software Solutions | N/A | |
| Suresh Amin | JB Chemicals Pharmaceuticals | N/A | |
| Aniruddha Chaudhuri | R S Software | 54 | |
| Abhishek Seal | R S Software | 44 | |
| M Rao | Tata Chemicals Limited | N/A | |
| Jason DSouza | JB Chemicals Pharmaceuticals | N/A | |
| Poonam Bhasin | Nucleus Software Exports | N/A | |
| Amin Suresh | JB Chemicals Pharmaceuticals | 56 | |
Management Performance
| Return On Equity | 0.0985 | ||||
| Return On Asset | 0.0665 |
DMCC SPECIALITY CHEMICALS Leadership Team
Elected by the shareholders, the DMCC SPECIALITY's board of directors comprises two types of representatives: DMCC SPECIALITY inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DMCC. The board's role is to monitor DMCC SPECIALITY's management team and ensure that shareholders' interests are well served. DMCC SPECIALITY's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DMCC SPECIALITY's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ashok Nagarch, Technical Development | ||
| S Jadhav, Senior Unit | ||
| Bimal Goculdas, CEO MD | ||
| Omkar Mhamunkar, Compliance Secretary | ||
| Mohan Pawar, Logistics Management | ||
| Sonal Naik, Company Officer | ||
| Shirish Pandit, Senior Division | ||
| Kuldeep Tiwari, Head Operations | ||
| Dilip Gokhale, Executive Director | ||
| Sunil Goyal, Chief Officer | ||
| Chirag Shah, Chief Officer | ||
| Deonath Shukla, Gen Marketing | ||
| Srinivas Rao, Head Business |
DMCC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DMCC SPECIALITY a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0985 | ||||
| Return On Asset | 0.0665 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 8.3 B | ||||
| Shares Outstanding | 24.94 M | ||||
| Shares Owned By Insiders | 65.54 % | ||||
| Price To Book | 3.36 X | ||||
| Price To Sales | 1.61 X | ||||
| Revenue | 4.31 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DMCC Stock Analysis
When running DMCC SPECIALITY's price analysis, check to measure DMCC SPECIALITY's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DMCC SPECIALITY is operating at the current time. Most of DMCC SPECIALITY's value examination focuses on studying past and present price action to predict the probability of DMCC SPECIALITY's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DMCC SPECIALITY's price. Additionally, you may evaluate how the addition of DMCC SPECIALITY to your portfolios can decrease your overall portfolio volatility.